Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Trends, Growth, Analysis, Size, Share and Forecast 2025

Asia-Pacific STD diagnostics market is growing at a CAGR of around 9.4% during the forecast period. The region has the second-highest HIV prevalence. Major countries such as China, India and Indonesia account for around three-quarters of the total number of people living with HIV. There is a huge variation across the region in terms of the incidence of HIV and countries' responses to the diagnosis and treatment. However, investments by countries with HIV diagnosis and treatment in the region have doubled over the last decade.

Get Sample Copy of Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market at: https://www.omrglobal.com/request-sample/asia-pacific-sexually-transmitted-disease-market

Key Players - Abbott Laboratories, Inc., AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc.

There is a significant increase in the incidence and prevalence of genital herpes and genital warts in the region. Gonorrhea is the most dominant STD in the region, with a high incidence of chromosomally-mediated resistant and penicillinase-producing strains comprising around 35%-50% of isolates. Clinical treatment failures due to spectinomycin-resistant gonococci are increasing in the APAC region. Uncontrolled antibiotic sales are responsible for these resistant strains. Further, STDs such as syphilis incidence was declined in 1950, however, it has re-emerged in the APAC region. The incidence of Cancroid is decreasing, while herpes is making up a greater share in the ulcer disease. The high incidence of STDs in this area is an indication of future trends of HIV/AIDS in the APAC region. The Asia-Pacific STD diagnostics market is strongly fueled by the rapid spread of human papilloma virus infection among the female population.

For More Information, get A full report of Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-sexually-transmitted-disease-market

In addition, supportive government initiatives and prevention programs are impacting the growth of Asia-Pacific STD diagnostics market as it has succeeded in reducing new HIV infections across the region. However, late diagnosis remains a key area of concern. Many countries in APAC have disciplinary and stigmatizing laws in place, which prevent members of key affected individuals from accessing services and work to support HIV stigma. According to UNAID (Joint United Nations Program on HIV/AIDS), in 2018, there were approximately 310,000 new infections in the region. The progress in reducing new infections has slowed in recent years and new HIV infections are on the rise in some countries of the region.

Market Segmentation

Asia-Pacific STD Diagnostics Market by Disease Type

o Chlamydia
o Syphilis
o Gonorrhea
o Herpes Simplex Virus (HSV)
o Human Papilloma Virus (HPV)
o Human Immunodeficiency Virus (HIV)
o Others

Asia-Pacific STD Diagnostics Market by Product

o Laboratory Testing Devices
o Point-of-Care (POC) Testing Devices

Asia-Pacific STD Diagnostics Market by End-user

o Hospitals and Clinics
o Diagnostic Centers
o Homecare

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-sexually-transmitted-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.